Unilife Corporation Provides Business Update

Unilife had $21.1 million in total cash and cash equivalents, including restricted cash of $2.4 million, as of June 30, 2016.

Conference Call Information

Management has scheduled a conference call for 4:30 p.m. EDT on Wednesday, November 2, 2016 (Thursday, November 3, 2016 at 7:30 a.m. AEDT) to review the Company's financial results and future outlook. The conference call will be broadcast over the Internet as a "live" listen-only webcast. An archive of the webcast will be available for 30 days after the call. To listen, go to: http://ir.unilife.com/events.cfm.

About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife has a portfolio of innovative, differentiated products with a primary focus on wearable injectors. Products within each platform are customizable to address specific customer, drug and patient requirements. Unilife's global headquarters and manufacturing facilities are located in York, PA.  For more information, visit www.unilife.com.

Forward-Looking Statements
This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission ("SEC") on October 24, 2016 and those described from time to time in other reports which we file with the SEC. 

General: UNIS-G

Investor Contact (US):
Jeremy Feffer
Unilife Corporation
+1-717-384-3450
investors@unilife.com

Investor Contact (Australia):
Jeff Carter
Unilife Corporation
+61 2 8346 6500

UNILIFE CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
	June 30, 2016		June 30, 2015
	(in thousands, except share data)
Assets
Current Assets:
Cash and cash equivalents	$                          18,702		$                          12,303
Restricted cash	2,400		2,400
Restricted cash - related party	-		2,264
Accounts receivable	374		1,530
Inventories	89		151
Prepaid expenses and other current assets	1,645		656
Total current assets	23,210		19,304
Property, plant and equipment, net	54,773		66,148
Goodwill	9,423		9,685
Other assets	255		276
Total assets	$                          87,661		$                          95,413
Liabilities and Stockholders' Deficit
Current Liabilities:
Accounts payable	$                            2,662		$                            4,042
Due to related party	-		2,264
Accrued expenses	13,710		5,074
Current portion of long-term debt	669		775
Deferred revenue	1,660		4,942
Total current liabilities	18,701		17,097
Long-term debt, less current portion	104,445		78,680
Warrant Liability	3,351		-
Derivative Liability	347		-
Deferred revenue	47,550		17,550
Total liabilities	174,394		113,327
Stockholders' Deficit:
Redeemable convertible preferred stock, Series A - subject to redemption, $0.01 par value, 790 and 0 shares authorized, 0 and 0 shares issued, and 0 and 0 shares outstanding as of June 30, 2016 and June 30, 2015, respectively	-		-
Preferred stock, $0.01 par value, 50,000,000 shares authorized as of June 30, 2016;   none issued or outstanding  as of June 30, 2016 and June 30, 2015	-		-
Common stock, $0.01 par value, 350,000,000 shares authorized as of June 30, 2016;   17,488,032 and 13,197,616 shares issued, and 17,411,651 and 13,194,749 shares   outstanding as of June 30, 2016 and June 30, 2015, respectively Werbung Mehr Nachrichten zur Unilife CDIS Aktie kostenlos abonnieren E-Mail-Adresse Bitte überprüfe deine die E-Mail-Adresse. Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1 Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News 12:33 - PR Newswire Fidelity Asian Values Plc - Transaction in Own Shares 12:06 - PR Newswire BH Macro Limited - Transaction in Own Shares 09:58 - PR Newswire Wood Group (John) Plc - Director/PDMR Shareholding Der KI-Boom ist vorbei!    Aber dieser heiße Sektor verspricht, weiter zu wachsen... weiterlesen» Anzeige wo-site-teaser-box-16737_site-teaser-box_2024-04-23_09%253A00%253A00_2024-04-24_09%253A00%253A59